FSPs

R&D

Organisations must remain agile and decisive across global portfolios, anticipating regulatory changes before they create clinical trial delays.

Market Access

Clinical research is full of challenges, from recruitment to data management to global resourcing.

News

MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.